Risk Factors for Bisphosphonate-Related Osteonecrosis of the Jaws

Journal of Oral and Maxillofacial Surgery

Volumn 67, Issue 11, 2009, Pages 2553-2554

  Kyrgidis, Athanassios ^a   Vahtsevanos, Konstantinos ^a  

^a THEAGENIO CANCER HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; IBANDRONIC ACID; PAMIDRONIC ACID; ZOLEDRONIC ACID;

CANCER RISK; DENTAL SURGERY; HUMAN; INCIDENCE; JAW OSTEONECROSIS; LETTER; RISK FACTOR; SMOKING; TOOTH EXTRACTION; TREATMENT DURATION;

BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; EVIDENCE-BASED DENTISTRY; HUMANS; JAW DISEASES; OSTEONECROSIS; RISK FACTORS;

EID: 70349869033     PISSN: 02782391     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joms.2009.06.029     Document Type: Letter

References (11)

1. Ruggiero S.L., Dodson T.B., Assael L.A., et al. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws-2009 Update. J Oral Maxillofac Surg 67 (2009) 2
2. Wilkinson G.S., Kuo Y.F., Freeman J.L., et al. Intravenous bisphosphonate therapy and inflammatory conditions or surgery of the jaw: A population-based analysis. J Natl Cancer Inst 99 (2007) 1016
3. Walter C., Al-Nawas B., Grotz K.A., et al. Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate. Eur Urol 54 (2008) 1066
4. Edwards B.J., Gounder M., Mckoy J.M., et al. Pharmacovigilance and reporting oversight in US FDA fast-track process: Bisphosphonates and osteonecrosis of the jaw. Lancet Oncol 9 (2008) 1166
5. Hess L.M., Jeter J.M., Benham-Hutchins M., et al. Factors associated with osteonecrosis of the jaw among bisphosphonate users. Am J Med 121 (2008) 475
6. Vahtsevanos K., Kyrgidis A., Verrou E., et al. Bisphosphonate related osteonecrosis of the jaws: A longitudinal cohort study of risk factors in cancer patients. J Clin Oncol (2009) in press
7. Kyrgidis A., Vahtsevanos K., Koloutsos G., et al. Bisphosphonate related osteonecrosis of the jaws: Risk factors in breast cancer patients-A case control study. J Clin Oncol 26 (2008) 4634
8. Hoff A.O., Toth B.B., Altundag K., et al. Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates. J Bone Miner Res 23 (2008) 826
9. Kyrgidis A., Triaridis S., Vahtsevanos K., et al. Osteonecrosis of the jaw and bisphosphonate use in breast cancer patients. Expert Review Anticancer Ther 9 (2009) 1125
10. Estilo C.L., Van Poznak C.H., Wiliams T., et al. Osteonecrosis of the maxilla and mandible in patients with advanced cancer treated with bisphosphonate therapy. Oncologist 13 (2008) 911
11. Kyrgidis A., and Vahtsevanos K. Increased risk for bisphosphonate related osteonecrosis of the jaws in patients wearing overdentures could be attributable to impaired mucosal cell wound healing. J Oral Maxillofac Surg 67 (2009) 1355